BET inhibitor resistance emerges from leukaemia stem cells. (2015)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nature14888
PubMed Identifier: 26367796
Publication URI: http://europepmc.org/abstract/MED/26367796
Type: Journal Article/Review
Volume: 525
Parent Publication: Nature
Issue: 7570
ISSN: 0028-0836